Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study

OBJECTIVE: Pharmaceutical treatment of latent tuberculosis infection (LTBI) reduces the risk of progression to active tuberculosis (TB); however, poor adherence tempers the protective effect. We aimed to estimate the health burden of non-adherence, the maximum allowable cost of hypothetical new adhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Anik R, Campbell, Jonathon R, Sadatsafavi, Mohsen, Marra, Fawziah, Johnston, James C, Smillie, Kirsten, Lester, Richard T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Open 2017
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640098/
https://www.ncbi.nlm.nih.gov/pubmed/28918407
http://dx.doi.org/10.1136/bmjopen-2016-015108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640098/
https://www.ncbi.nlm.nih.gov/pubmed/28918407
http://dx.doi.org/10.1136/bmjopen-2016-015108

Ejemplares similares